Home / Share Price Target / Maxhealth
Max Healthcare Share Price Target 2024, 2025, 2026 to 2039 With Charts
Max Healthcare Institute Limited | |||
 | Symbol: MAXHEALTH | ||
| Price: ₹999.95 | |||
| Exchange: NSE | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Max Healthcare Brief Company Overview
- 1.1: Max Healthcare Institute Limited: Empowering Healthcare in India
- 1.1.1: Key Products and Services:
- 1.1.2: Reputation and Commitment:
- 1.1.3: Market Presence:
- 1.2: Max Healthcare Financial Performance
- 1.2.1: Is Max Healthcare A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Max Healthcare Share Price Target For 2024
- 2.1.1: Max Healthcare Share Price Target Table For 2024
- 2.1.2: Summary: Max Healthcare Share Price Prediction For 2024
- 2.2: Max Healthcare Share Price Target For 2025
- 2.2.1: Max Healthcare Share Price Target Table For 2025
- 2.2.2: Summary: Max Healthcare Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Max Healthcare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Max Healthcare Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Max Healthcare Past Performance
Max Healthcare Brief Company Overview
Max Healthcare Institute Limited: Empowering Healthcare in India
Max Healthcare Institute Limited is a leading provider of comprehensive healthcare services in India, with a diverse portfolio catering to various medical specialties.
Key Products and Services:
- Bariatric surgery
- Bone marrow transplant
- Cancer/oncology
- Cardiac science
- Diagnostic services
- Endocrinology and diabetes
- Eye care
- Gastroenterology, hepatology, and endoscopy
- Kidney transplant
- Laparoscopic surgery
- Liver transplant
- Neuro science
- Orthopedics
- Robotic surgery
- Urology
- Vascular surgery
Reputation and Commitment:
Max Healthcare is renowned for its high-quality medical care and commitment to patient well-being. The company's mission is to "provide world-class healthcare at an affordable price."
Market Presence:
Max Healthcare operates a wide network of hospitals and medical centers across India, including locations in Delhi, Maharashtra, Punjab, Uttar Pradesh, and Uttarakhand.
Advertisement
Max Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,04,917.34 Crore | Market valuation of Max Healthcare's shares. |
| Revenue (TTM) | 6,008.27 Crore | Total revenue generated by Max Healthcare over the past twelve months. |
| Net Income (TTM) | +1,058.95 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 21.45% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 17.62% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +25.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +1.9% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 20.09 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,768.18 Crore | Sum of Max Healthcare's current & long-term financial obligations. |
| Total Cash | 1,286.3 Crore | Total amount of liquid funds available to Max Healthcare. |
| Beta | 0.27 | Beta is less than 1 indicating that the Max Healthcare's price is less volatile than the market. |
Is Max Healthcare A Good Buy For Long Term?
No valid response content found
To predict the Max Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Max Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Max Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Max Healthcare shares in 2024, see the table below.
Advertisement
Max Healthcare Share Price Target Table For 2024
| Max Healthcare's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1033.94 (+3.39%) | Price Action: 06 Nov 2024 Low |
| 2024 Target 2 | 1020.40 (+2.04%) | Price Action: 11 Nov 2024 Low |
| 2024 Target 1 | 1010.05 (+1.01%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 999.95 | Max Healthcare's 1 share price as of Wed 13 Nov 2024 |
| Stop Loss 1 | 996.00 (-0.4%) | Price Action: Sep 2024 High |
| Stop Loss 2 | 982.00 (-1.8%) | Price Action: 16 Oct 2024 High |
| Stop Loss 3 | 968.25 (-3.18%) | Price Action: 10 Oct 2024 High |
Summary: Max Healthcare Share Price Prediction For 2024
In summary, Max Healthcare has surged by ₹313.70, achieving a notable +45.71% increase from 1st January 2024 to 13 Nov 2024. Our analysis of Max Healthcare for 2024 predicts an additional rise of 1.01% to 3.39% by the end of 2024 with three potential targets T1: 1010.05, T2: 1020.40, T3: 1033.94. Stop Loss at SL1: 996.00, SL2: 982.00, SL3: 968.25.
Max Healthcare has a 52-week high of ₹1118.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹590.09, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Max Healthcare.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Max Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Max Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Max Healthcare shares in 2025, see the table below.
Advertisement
Max Healthcare Share Price Target Table For 2025
| Max Healthcare's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1340.99 (+34.1%) | Price Action: Chart |
| 2025 Target 2 | 1315.99 (+31.6%) | Price Action: Chart |
| 2025 Target 1 | 1302.96 (+30.3%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 999.95 | Max Healthcare's 1 share price as of Wed 13 Nov 2024 |
| Stop Loss 1 | 927.95 (-7.21%) | Price Action: Jul 2024 High |
| Stop Loss 2 | 915.25 (-8.48%) | Price Action: Jul 2024 Low |
| Stop Loss 3 | 902.45 (-9.76%) | Price Action: 25 Oct 2024 Low |
Summary: Max Healthcare Share Price Prediction For 2025
In summary, Max Healthcare has surged by ₹313.70, achieving a notable +45.71% increase from 1st January 2024 to 13 Nov 2024. Our analysis of Max Healthcare for 2025 predicts an additional rise of 30.3% to 34.1% by the end of 2025 with three potential targets T1: 1302.96, T2: 1315.99, T3: 1340.99. Stop Loss at SL1: 927.95, SL2: 915.25, SL3: 902.45.
Max Healthcare has a All-Time high of ₹1118.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹590.09, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Max Healthcare, we have created a specific page for that check here: Max Healthcare Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Max Healthcare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Max Healthcare share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 12.71% over the next 15 years.
For complete year by year Max Healthcare long term share price target from 2024, 2025 to 2039 check the below table.
Max Healthcare Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Max Healthcare Target | YoY Change % |
|---|---|---|
| 2024 | ₹999.95 | [Current Price] |
| 2024 | ₹1,055.17 | 5.52% |
| 2025 | ₹1,407.48 | 33.38% |
| 2026 | ₹1,624.15 | 15.39% |
| 2027 | ₹1,932.74 | 19% |
| 2028 | ₹2,374.87 | 22.87% |
| 2029 | ₹2,589.79 | 9.04% |
| 2030 | ₹2,993.23 | 15.57% |
| 2031 | ₹3,117.52 | 4.15% |
| 2032 | ₹3,433.8 | 10.14% |
| 2033 | ₹3,971.34 | 15.65% |
| 2034 | ₹4,124.39 | 3.85% |
| 2035 | ₹4,578.97 | 11.02% |
| 2036 | ₹4,610.88 | 0.69% |
| 2037 | ₹4,934.85 | 7.02% |
| 2038 | ₹5,567.81 | 12.82% |
| 2039 | ₹5,635.62 | 1.21% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Max Healthcare Past Performance
- In 2020, Max Healthcare opening price was ₹101.1
- As of Wed 13 Nov 2024 the price stands at ₹999.95.
- This represents a Compound Annual Growth Rate (CAGR) of 58.14%.
- In 4 years, an investment of 10,000 would have become ₹98,907.02.
As we wrap up, we hope you like our study on Max Healthcare share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Max Healthcare Share Price History
- Max Healthcare Price Target Tomorrow
- Max Healthcare Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
